| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.00B | -15.3% |
| Cost of Revenue | $4.01B | +3.8% |
| Gross Profit | $1.98B | -38.3% |
| R&D Expense | $583.6M | -4.7% |
| SG&A Expense | $348.9M | -7.3% |
| Operating Income | $84.2M | -95.2% |
| Pre-tax Income | $131.3M | -92.9% |
| Income Tax | $7.7M | -97.1% |
| Net Income | $121.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.15B | -20.2% |
| Short-term Investments | $400.0M | +33.3% |
| Accounts Receivable | $908.0M | -21.7% |
| Inventory | $1.99B | -11.3% |
| Current Assets | $5.82B | -13.8% |
| Total Assets | $12.52B | -11.1% |
| Current Liabilities | $1.29B | -3.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.76B | -7.7% |
| Capital Expenditures | $341.2M | -50.8% |
| Investing Cash Flow | -$538.5M | +46.7% |
| Financing Cash Flow | -$1.76B | -157.9% |
| Free Cash Flow | $1.42B | +17.0% |
| -92.3% |
| EPS (Basic) | $0.29 | -92.1% |
| EPS (Diluted) | $0.29 | -92.0% |
| Long-term Debt |
| $2.98B |
| -11.8% |
| Total Liabilities | $4.83B | -8.4% |
| Stockholders' Equity | $7.67B | -12.8% |